Lifen Wang
Impact in
- Aging top 1%
- Genetics, Aging, and Longevity in Model Organisms
- Molecular Medicine top 5%
- Hydrogels: synthesis, properties, applications
Papers in
-
- Hydrogels: synthesis, properties, applications 7
-
- Advanced Drug Delivery Systems 7
- Co-authors
- Heinrich Jasper (5 shared papers)Helin Xu (16 shared papers)Ying‐Zheng Zhao (13 shared papers)Hyung Don Ryoo (2 shared papers)Qing Yao (9 shared papers)Jason Karpac (2 shared papers)Shiru Jia (1 shared paper)Zheng Li (1 shared paper)
- Journals
- Artificial Cells Nanomedicine and Biotechnology (2 papers)Frontiers in Neurology (2 papers)Frontiers in Pharmacology (2 papers)International Journal of Biological Macromolecules (2 papers)PLoS Genetics (2 papers)
- Partner nations
- ChinaUnited StatesHungary
In The Last Decade
Lifen Wang
81 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 108
- Aging 170
- Molecular Medicine 129
- Biomaterials 238
- Pharmaceutical Science 113
- Drug Discovery 4
Countries citing papers authored by Lifen Wang
This map shows the geographic impact of Lifen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifen Wang more than expected).
Fields of papers citing papers by Lifen Wang
This network shows the impact of papers produced by Lifen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifen Wang. The network helps show where Lifen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lifen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 148 | |
| 2 | 2021 | 108 | |
| 3 | 2014 | 101 | |
| 4 | 2015 | 89 | |
| 5 | 2013 | 77 | |
| 6 | 2021 | 61 | |
| 7 | 2014 | 60 | |
| 8 | 2020 | 60 | |
| 9 | 2016 | 58 | |
| 10 | 2013 | 53 | |
| 11 | 2021 | 50 | |
| 12 | 2019 | 49 | |
| 13 | 2017 | 48 | |
| 14 | 2019 | 48 | |
| 15 | 2019 | 45 | |
| 16 | 2020 | 45 | |
| 17 | 2021 | 43 | |
| 18 | 2018 | 39 | |
| 19 | 2023 | 37 | |
| 20 | 2013 | 35 |
About Lifen Wang
Lifen Wang is a scholar working on Molecular Medicine, Pharmaceutical Science, Hepatology, Aging and Cancer Research, having authored 85 papers that have together received 1.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (8 papers), Advanced Drug Delivery Systems (7 papers), Hydrogels: synthesis, properties, applications (7 papers), Acupuncture Treatment Research Studies (6 papers), Liver Disease and Transplantation (5 papers), Genetics, Aging, and Longevity in Model Organisms (5 papers), Cancer-related molecular mechanisms research (4 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Aging (170 citations), Molecular Medicine (129 citations), Biomaterials (238 citations), Pharmaceutical Science (113 citations) and Drug Discovery (4 citations). Lifen Wang has collaborated with scholars based in China, United States and Hungary. Frequent co-authors include Heinrich Jasper, Helin Xu, Ying‐Zheng Zhao, Hyung Don Ryoo, Qing Yao, Jason Karpac, Shiru Jia, Zheng Li, Jianfei Zhang and Jiachuan Hua. Their work appears in journals such as Artificial Cells Nanomedicine and Biotechnology, Frontiers in Neurology, Frontiers in Pharmacology, International Journal of Biological Macromolecules and PLoS Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.